Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, de Souza Silva TB, Alves PA, da Rocha Fernandes G, de Oliveira JG, Rahal P, Grenfell RFQ, Nogueira ML. Campos GRF, et al. Among authors: de assis jv, de miranda dap, de souza silva tb, de oliveira jg. Commun Med (Lond). 2022 Jun 29;2:76. doi: 10.1038/s43856-022-00141-4. eCollection 2022. Commun Med (Lond). 2022. PMID: 35784447 Free PMC article.
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, de Souza Silva TB, Alves PA, da Rocha Fernandes G, de Oliveira JG, Rahal P, Queiroz RFG, Nogueira ML. Campos GRF, et al. Among authors: de assis jv, de miranda dap, de souza silva tb, de oliveira jg. medRxiv [Preprint]. 2022 Mar 25:2022.03.24.22272904. doi: 10.1101/2022.03.24.22272904. medRxiv. 2022. PMID: 35350193 Free PMC article. Updated. Preprint.
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Among authors: de abreu dpb, de miranda dap, de oliveira jg. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.
Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, Silva TBS, Alves PA, Fernandes GDR, de Oliveira JG, Rahal P, Grenfell RFQ, Nogueira ML. Campos GRF, et al. Among authors: de oliveira jg. Front Cell Infect Microbiol. 2024 Apr 4;14:1371695. doi: 10.3389/fcimb.2024.1371695. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38638823 Free PMC article.
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, Fonseca CT, Teixeira-Carvalho A, Villela-Rezende G, Santos RA, Batista MA, Campos FM, Pacheco-Porto L, Melo Júnior OA, Hossell DM, Coelho-dos-Reis JG, Peruhype-Magalhães V, Costa-Silva MF, de Oliveira JG, Farias RH, Noronha TG, Lemos JA, von Doellinger Vdos R, Simões M, de Souza MM, Malaquias LC, Persi HR, Pereira JM, Martins JA, Dornelas-Ribeiro M, Vinhas Ade A, Alves TR, Maia Mde L, Freire Mda S, Martins Rde M, Homma A, Romano AP, Domingues CM, Tauil PL, Vasconcelos PF, Rios M, Caldas IR, Camacho LA, Martins-Filho OA. Campi-Azevedo AC, et al. Among authors: de souza mm, de oliveira jg. Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693. Hum Vaccin Immunother. 2016. PMID: 26360663 Free PMC article.
Free-living amoebae and their relationship to air quality in hospital environments: characterization of Acanthamoeba spp. obtained from air-conditioning systems.
Wopereis DB, Bazzo ML, de Macedo JP, Casara F, Golfeto L, Venancio E, de Oliveira JG, Rott MB, Caumo KS. Wopereis DB, et al. Among authors: de oliveira jg, de macedo jp. Parasitology. 2020 Jun;147(7):782-790. doi: 10.1017/S0031182020000487. Epub 2020 Mar 18. Parasitology. 2020. PMID: 32183918 Free PMC article.
Nitric oxide synthase expression correlates with death in an experimental mouse model of dengue with CNS involvement.
de Souza KP, Silva EG, de Oliveira Rocha ES, Figueiredo LB, de Almeida-Leite CM, Arantes RM, de Assis Silva Gomes J, Ferreira GP, de Oliveira JG, Kroon EG, Campos MA. de Souza KP, et al. Among authors: de almeida leite cm, de assis silva gomes j, de oliveira rocha es, de oliveira jg. Virol J. 2013 Aug 26;10:267. doi: 10.1186/1743-422X-10-267. Virol J. 2013. PMID: 23978258 Free PMC article.
HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis.
Alvarenga DLR, Silva AHDS, Fiuza JA, Gaze ST, de Oliveira JG, Oliveira RC, Calzavara-Silva CE, Pascoal-Xavier MA, Alves ÉAR. Alvarenga DLR, et al. Among authors: oliveira rc, de oliveira jg. Int Immunopharmacol. 2018 Jul;60:179-188. doi: 10.1016/j.intimp.2018.04.044. Epub 2018 May 7. Int Immunopharmacol. 2018. PMID: 29747123
Dengue virus 2 American-Asian genotype identified during the 2006/2007 outbreak in Piauí, Brazil reveals a Caribbean route of introduction and dissemination of dengue virus in Brazil.
Barcelos Figueiredo L, Sakamoto T, Leomil Coelho LF, de Oliveira Rocha ES, Gomes Cota MM, Ferreira GP, de Oliveira JG, Kroon EG. Barcelos Figueiredo L, et al. Among authors: de oliveira rocha es, de oliveira jg. PLoS One. 2014 Aug 15;9(8):e104516. doi: 10.1371/journal.pone.0104516. eCollection 2014. PLoS One. 2014. PMID: 25127366 Free PMC article.
116 results